Literature DB >> 12697993

Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines.

A Weise1, T Liehr, T Efferth, A Kuechler, E Gebhart.   

Abstract

Cell lines of human T-cell acute lymphoblastic leukemias (T-ALL) have gained high interest for study of mechanisms of cytostatic drug resistance. However, they should also be suited to examine the validity and reliability of molecular cytogenetic techniques in detecting genomic alterations in neoplastic cells. Therefore, comparative genomic hybridization (CGH) and 24-color-fluorescence-in-situ-hybridization (M-FISH) were applied to eight sublines of CCRF-CEM leukemia cells selected in vitro for drug resistance and to their drug-sensitive parental counterparts. All cell lines were characterized by altered chromosome numbers and by a variety of chromosomal structural aberrations as shown by M-FISH. The great majority of anomalies detected by this technique were confirmed by CGH. Interestingly, a considerable number of the rearrangements found were imbalanced. Amplifications of 5q13 in the six methotrexate-resistant cell lines, a del(9)(p21pter) in all lines examined, and a gain of chromosome 20 in 9 of the 10 lines examined were readily detected by both techniques. The same held true for losses of chromosomes 17 and 18 in the near tetraploid cell lines which could also be confirmed by CGH. Some imbalances of genomic material detected by CGH were, however, not observed by means of M-FISH, possibly due to the limited extension of the corresponding chromosomal segment involved or the small subpopulation of cells affected. On the other hand, reciprocal translocations, balanced isochromosomes, and small deletions remained mainly undetected by CGH. A comparison of chromosomal alterations in drug-resistant and parental cell lines showed not only amplifications of chromosomal segments harboring well-known drug resistance genes, e.g., the dihydrofolate reductase gene, but also chromosomal changes which may involve novel genes associated with drug resistance. Thus, the present study has clearly unveiled the strengths and weaknesses of both techniques which can excellently complement each other. Their combination allowed a distinct improvement of the definition of the complex karyotypes of drug-resistant cell lines. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12697993     DOI: 10.1159/000069808

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  4 in total

1.  Comprehensive characterization of genomic instability in pluripotent stem cells and their derived neuroprogenitor cell lines.

Authors:  Nestor Luis Lopez Corrales; Kristin Mrasek; Martin Voigt; Thomas Liehr; Nadezda Kosyakova
Journal:  Appl Transl Genom       Date:  2012-08-29

2.  Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia.

Authors:  Maria Luiza Macedo Silva; Maria do Socorro Pombo-de-Oliveira; Susana C Raimondi; Hasmik Mkrtchyan; Eliana Abdelhay; Amanda Faria de Figueiredo; Mariana Tavares de Souza; Daniela Ribeiro Ney Garcia; Eliane Maria Soares de Ventura; Adriana Martins de Sousa; Thomas Liehr
Journal:  Mol Cytogenet       Date:  2009-02-19       Impact factor: 2.009

3.  Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization.

Authors:  Donatella Caserta; Moncef Benkhalifa; Marina Baldi; Francesco Fiorentino; Mazin Qumsiyeh; Massimo Moscarini
Journal:  Mol Cytogenet       Date:  2008-05-20       Impact factor: 2.009

4.  Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.

Authors:  Onat Kadioglu; Jingming Cao; Nadezda Kosyakova; Kristin Mrasek; Thomas Liehr; Thomas Efferth
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.